41 – 50 of 64
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Alpha-Synuclein Repeat Variants and Survival in Parkinson's Disease
- Contribution to journal › Article
-
Mark
A porous silicon immunoassay platform for fluorometric determination of alpha-synuclein in human cerebrospinal fluid
- Contribution to journal › Article
-
Mark
Anti-amyloid compounds inhibit α-synuclein aggregation induced by protein misfolding cyclic amplification (PMCA)
- Contribution to journal › Article
-
Mark
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants
- Contribution to journal › Article
- 2013
-
Mark
Cholinergic and dopaminergic aspects of dementia in Parkinson's disease: postmortem neuropathological findings and modeling of cognitive dysfunction in rodents
- Thesis › Doctoral thesis (compilation)
-
Mark
Boosting chaperone-mediated autophagy in vivo mitigates alpha-synuclein-induced neurodegeneration
- Contribution to journal › Article
-
Mark
What's to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
- Contribution to journal › Article
-
Mark
LAMP2A as a therapeutic target in Parkinson disease
- Contribution to journal › Debate/Note/Editorial
-
Mark
Animal Models of Parkinson's Disease: Limits and Relevance to Neuroprotection Studies
- Contribution to journal › Scientific review
-
Mark
Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease
- Contribution to journal › Article
